Atossa Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $5.0M | $76.4M | $71.1M |
| FY2025 | $8.3M | $47.6M | $41.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $5.0M | $76.4M | $71.1M |
| FY2025 | $8.3M | $47.6M | $41.3M |